series-c-plus
Stage
1
Investors
About
Phagenesis is a medical device company developing neurostimulation technology to treat dysphagia (swallowing difficulties). Their lead product, Phagenyx®, aims to restore swallowing function in patients.
Explore Phagenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.